Correlation Between Oryzon Genomics and Atrys Health

Can any of the company-specific risk be diversified away by investing in both Oryzon Genomics and Atrys Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oryzon Genomics and Atrys Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oryzon Genomics SA and Atrys Health SL, you can compare the effects of market volatilities on Oryzon Genomics and Atrys Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oryzon Genomics with a short position of Atrys Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oryzon Genomics and Atrys Health.

Diversification Opportunities for Oryzon Genomics and Atrys Health

0.44

Correlation Coefficient

Oryzon Genomics  Atrys Health

Very weak diversification

The 3 months correlation between Oryzon and Atrys is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and Atrys Health SL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atrys Health SL and Oryzon Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oryzon Genomics SA are associated (or correlated) with Atrys Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atrys Health SL has no effect on the direction of Oryzon Genomics i.e., Oryzon Genomics and Atrys Health go up and down completely randomly.

Pair Corralation between Oryzon Genomics and Atrys Health

Assuming the 90 days trading horizon Oryzon Genomics SA is expected to under-perform the Atrys Health. But the stock apears to be less risky and, when comparing its historical volatility, Oryzon Genomics SA is 1.19 times less risky than Atrys Health. The stock trades about -0.2 of its potential returns per unit of risk. The Atrys Health SL is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  320.00  in Atrys Health SL on September 13, 2024 and sell it today you would lose (14.00) from holding Atrys Health SL or give up 4.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Oryzon Genomics SA  vs.  Atrys Health SL

Oryzon Genomics SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Atrys Health SL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Atrys Health SL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Atrys Health is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Oryzon Genomics and Atrys Health

The main advantage of trading using opposite Oryzon Genomics and Atrys Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oryzon Genomics position performs unexpectedly, Atrys Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atrys Health will offset losses from the drop in Atrys Health's long position.

The idea behind Oryzon Genomics SA and Atrys Health SL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.